Severity of sleep apnea impairs adipose tissue insulin sensitivity in individuals with obesity and newly diagnosed obstructive sleep apnea.

INTRODUCTION

Obstructive sleep apnea (OSA) is a common sleep disorder associated with increased risk for the development of type 2 diabetes. While studies have examined the effects of sleep on whole-body insulin sensitivity, little is known about the effects of sleep on adipose tissue insulin sensitivity in patients with OSA. We analyzed if the severity of OSA, measured by apnea-hypopnea index (AHI), is associated with adipose tissue insulin sensitivity.

METHODS

We examined the relationship between sleep parameters and adipose tissue insulin sensitivity in non-diabetic participants with obesity and newly diagnosed OSA who underwent overnight polysomnography and a 2 h oral glucose tolerance test during which circulating free fatty acids were measured. In total, 16 non-diabetic participants with obesity and newly diagnosed OSA (sex, 81.3% males; mean age, 50.9 ± 6.7 y; BMI, 36.5 ± 2.9 kg/m; AHI, 43 ± 20 events/h) were included in the analysis.

RESULTS

In our study participants, AHI is inversely associated with free-fatty acid suppression during oral glucose challenge ( = -0.764, = 0.001). This relationship persisted even after statistical adjustment for age ( = -0.769, = 0.001), body mass index ( = -0.733, = 0.002), waist-to-hip ratio ( = -0.741, = 0.004), or percent body fat mass ( = -0.0529, = 0.041). Furthermore, whole-body insulin sensitivity as determined by the Matsuda index was associated with percent REM sleep ( = 0.552, = 0.027) but not AHI ( = -0.119, = 0.660).

CONCLUSION

In non-diabetic patients with OSA, the severity of sleep apnea is associated with adipose tissue insulin sensitivity but not whole-body insulin sensitivity. The impairments in adipose tissue insulin sensitivity may contribute to the development of type 2 diabetes.